MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinsonism in a case of Gerstmann Sträussler Scheinker disease

S. Poveda, O. Bernal-Pacheco, L. Lancheros, J. Montealegre (Bogotá, Colombia)

Meeting: 2025 International Congress

Keywords: Parkinsonism, Prion diseases. See Transmissible spongiform encephalopathies, Prion protein gene(PRNP)

Category: Parkinsonism (Other)

Objective: Describe an atypical presentation of Gerstmann-Sträussler-Scheinker disease (GSS) with predominant parkinsonism due to the PRNP P102L mutation, emphasizing intrafamilial variability and diagnostic challenges in Colombia.

Background: GSS, a rare autosomal dominant prion disease caused by PRNP mutations, typically presents with cerebellar ataxia and dementia. The P102L variant is classically linked to ataxia, but this case highlights parkinsonism as the initial manifestation, a rare phenotype. Underreporting in Colombia obscures disease incidence and clinical diversity.

Method: A 55-year-old Colombian woman with progressive parkinsonism, dysphagia, and cognitive decline underwent neurologic evaluation, brain MRI, electromyography, and whole-genome sequencing. Familial genetic testing and counseling were conducted.

Results: Clinical evaluation revealed rigidity, bradykinesia, resting tremor, and rapid functional decline. MRI showed nonspecific white matter hyperintensities without cerebellar atrophy. Genetic testing confirmed the heterozygous PRNP P102L mutation. Thirteen family members were diagnosed, four confirmed genetically, with similar parkinsonian onset. Levodopa provided partial symptom relief. The patient died within two years from pneumonia.

Conclusion: This case underscores GSS’s phenotypic variability, even with the P102L mutation, and challenges the classic ataxia-dominant presentation. Parkinsonism as an initial feature necessitates prion disease inclusion in atypical parkinsonism differentials. Genetic testing enables early diagnosis, family counseling, and palliative planning. Colombian underreporting highlights the need for improved surveillance.

Figure 1. Family pedigree

Figure 1. Family pedigree

References: 1. Eraña, H., San Millán, B., Díaz-Domínguez, C.M. et al. Description of the first Spanish case of Gerstmann–Sträussler–Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization. J Neurol 269, 4253–4263 (2022). https://doi.org/10.1007/s00415-022-11051-9
2. Ufkes, N.A., Woodard, C. & Dale, M.L. A case of Gerstmann-Straussler-Scheinker (GSS) disease with supranuclear gaze palsy. J Clin Mov Disord 6, 7 (2019). https://doi.org/10.1186/s40734-019-0082-1
3. Shin M, Kim D, Heo YJ, Baek JW, Yun S, Jeong HW. Gerstmann-Sträussler-Scheinker Disease: A Case Report. J Korean Soc Radiol. 2023 May;84(3):745-749. doi: 10.3348/jksr.2022.0089.
4. Smid J, Studart A Neto, Landemberger MC, Machado CF, Nóbrega PR, Canedo NHS, Schultz RR, Naslavsky MS, Rosemberg S, Kok F, Chimelli L, Martins VR, Nitrini R. High phenotypic variability in Gerstmann-Sträussler-Scheinker disease. Arq Neuropsiquiatr. 2017 Jun;75(6):331-338. doi: 10.1590/0004-282X20170049.
5. Tesar A, Matej R, Kukal J, Johanidesova S, Rektorova I, Vyhnalek M, Keller J, Eliasova I, Parobkova E, Smetakova M, Musova Z, Rusina R. Clinical Variability in P102L Gerstmann-Sträussler-Scheinker Syndrome. Ann Neurol. 2019 Nov;86(5):643-652. doi: 10.1002/ana.25579. Epub 2019 Sep 4. PMID: 31397917.
6. Chen Z, Guo J, Ran N, Zhong Y, Yang F, Sun H. A family with mental disorder as the first symptom finally confirmed with Gerstmann-Sträussler-Scheinker disease with P102L mutation in PRNP gene – case report. Prion. 2023 Dec;17(1):37-43. doi: 10.1080/19336896.2023.2180255.
7. Yoshimura M, Yuan JH, Higashi K, Yoshimura A, Arata H, Okubo R, Nakabeppu Y, Yoshiura T, Takashima H. Correlation between clinical and radiologic features of patients with Gerstmann-Sträussler-Scheinker syndrome (Pro102Leu). J Neurol Sci. 2018 Aug 15;391:15-21. doi: 10.1016/j.jns.2018.05.012.
8. Deters KD, Risacher SL, Yoder KK, Oblak AL, Unverzagt FW, Murrell JR, Epperson F, Tallman EF, Quaid KA, Farlow MR, Saykin AJ, Ghetti B. [(11)C]PiB PET in Gerstmann-Sträussler-Scheinker disease. Am J Nucl Med Mol Imaging. 2016 Jan 28;6(1):84-93. PMID: 27069768; PMCID: PMC4749507.
9. Baiardi S, Rizzi R, Capellari S, Bartoletti-Stella A, Zangrandi A, Gasparini F, Ghidoni E, Parchi P. Gerstmann-Sträussler-Scheinker disease (PRNP p.D202N) presenting with atypical parkinsonism. Neurol Genet. 2020 Feb 14;6(2):e400. doi: 10.1212/NXG.0000000000000400.
10. Stephen CD, de Gusmao CM, Srinivasan SR, Olsen A, Freua F, Kok F, Montes Garcia Barbosa R, Chen JYH, Appleby BS, Prior T, Frosch MP, Schmahmann JD. Gerstmann-Sträussler-Scheinker Disease Presenting as Late-Onset Slowly Progressive Spinocerebellar Ataxia, and Comparative Case Series with Neuropathology. Mov Disord Clin Pract. 2024 Apr;11(4):411-423. doi: 10.1002/mdc3.13976. Epub 2024 Jan 23. Erratum in: Mov Disord Clin Pract. 2024 May 2. doi: 10.1002/mdc3.14058. PMID: 38258626; PMCID: PMC10982592.

To cite this abstract in AMA style:

S. Poveda, O. Bernal-Pacheco, L. Lancheros, J. Montealegre. Parkinsonism in a case of Gerstmann Sträussler Scheinker disease [abstract]. Mov Disord. 2025; 40 (suppl 1). https://www.mdsabstracts.org/abstract/parkinsonism-in-a-case-of-gerstmann-straussler-scheinker-disease/. Accessed October 5, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2025 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsonism-in-a-case-of-gerstmann-straussler-scheinker-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Insulin dependent diabetes and hand tremor
  • Improvement in hand tremor following carpal tunnel release surgery
  • Impact of expiratory muscle strength training (EMST) on phonatory performance in Parkinson's patients
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley